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Objective. Uric acid may be linked to bone health through its antioxidant or prooxidant effects, thereby affecting bone resorption and formation, or through its dual inhibition of vitamin D activation and parathyroid hormone production. Results of prior studies on the relationship between uric acid and bone mineral density have been conflicting. This prospective study was undertaken to examine the relationship between gout, a disease characterized by hyperuricemia and inflammation, and risk of hip or wrist fracture in women.
Methods. We conducted a prospective observational study of gout and risk of incident wrist and hip fracture in women participating in the Nurses' Health Study (n 5 103,799 at baseline, with 14 years of follow-up for the wrist fracture analysis and 22 years of follow-up for the hip fracture analysis). Gout history and incident cases of wrist and hip fracture were assessed by biennial questionnaire. Cox proportional hazards models were used to simultaneously adjust for potential confounders.
Results. In this cohort, there were 3,769 incident wrist fractures (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) ) and 2,147 incident hip fractures , with 107 wrist fractures and 117 hip fractures occurring in participants with gout. In those women with a history of gout compared with women without gout, the multivariable-adjusted relative risk of wrist fracture was 1.12 (95% confidence interval [95% CI] 0.92-1.36) and the multivariable-adjusted relative risk of hip fracture was 1.38 (95% CI 1.14-1.68).
Conclusion. In women, a history of gout is associated with a modestly increased risk of hip fracture, but not significantly associated with a risk of wrist fracture.
Gout is a common inflammatory arthritis that is associated with hyperuricemia (1), and its prevalence and incidence have increased in recent years (2) (3) (4) . There is growing recognition that gout is not a disease affecting just men. It can also affect women, who share a substantial disease burden (5, 6 ) that involves significant costs (7), morbidities (8) (9) (10) (11) , and mortality (12, 13) .
Uric acid has been hypothesized to be related to bone health through its antioxidant or prooxidant properties, or through the vitamin D-parathyroid hormone (PTH) axis (14) (15) (16) . Even though uric acid can potentially act as an antioxidant against oxidative stress (17) , its role as either an antioxidant or prooxidant factor depends on the specific conditions (18) (19) (20) . When uric acid exists at supersaturated concentrations, such as in gout (21) , its antioxidant properties could be overcome by its prooxidant effects, thus creating an environment of high oxidative stress despite the presence of high uric acid levels in the serum (22) . The prooxidant role of uric acid can contribute to an inflammatory milieu, characterized by increased levels of circulating proinflammatory cytokines (e.g., tumor necrosis factor, interleukin-1 [IL-1], IL-6, and IL-17), thereby promoting bone resorption and inhibiting bone formation (23) (24) (25) (26) , which could ultimately increase the risk of osteoporotic fracture. Hyperuricemia can also inhibit vitamin D activation by suppressing 1-a-hydroxylase, resulting in a lower 1,25-dihydroxyvitamin D level and higher PTH level (15) . In addition, in humans, higher serum uric acid levels have been found to be associated with higher PTH levels (16) .
Results of prior studies on the relationship between the serum uric acid level and bone mineral density (BMD) have been conflicting. Cross-sectional studies in women demonstrated that a higher serum uric acid level was associated with a higher BMD at all skeletal sites, independent of body mass index (BMI) (27) (28) (29) . However, another cross-sectional study showed that the serum uric acid level was inversely associated with BMD (30) . Nevertheless, in a more recent study, investigators found no cross-sectional association between the serum uric acid level and BMD in a human population, as well as in a rat model (31) .
The studies that have examined the association between uric acid level and fracture have also yielded conflicting results. A cross-sectional study in Australian men showed that a higher serum uric acid level was associated with a lower prevalence of vertebral fracture and a history of nonvertebral fractures (32) . In the prospective study Osteoporotic Fractures in Men (MrOS), a higher serum uric acid level was associated with a lower risk of nonspine fracture, but there was no association with hip fracture (33) . In another prospective study, the Cardiovascular Health Study, a higher uric acid level was associated with a higher risk of hip fracture in men, but there was no association with hip fracture in women (34) . However, in a more recent prospective study from Rotterdam, a higher serum uric acid level was associated with a slightly lower risk of any type of incident fracture, but there was no association with hip fracture (35) .
Although hyperuricemia plays a recognized role in the development of gout, gout is a distinct clinical entity that also involves monosodium urate monohydrate crystal formation, which can also contribute to the inflammatory milieu (36) (37) (38) (39) . However, to date, there have been no prospective studies examining the relationship between gout and the risk of incident wrist or hip fracture in women. Therefore, the purpose of this study was to examine the prospective association between gout and risk of incident hip or wrist fracture in women participating in the Nurses' Health Study.
PATIENTS AND METHODS
Study population. The Nurses' Health Study is an ongoing prospective cohort study that began in 1976 with the enrollment of 121,700 female registered nurses between the ages of 30 years and 55 years. The cohort continues to be followed up with biennial mailed questionnaires that ask about lifestyle practices, medications, and newly diagnosed diseases. The follow-up rate has been .90% per eligible person-time of follow-up. Deaths are confirmed through the National Death Index. Approximately 98% of the cohort is white.
Participants in the Nurses' Health Study were included in the present analysis if they did not have a history of wrist or hip fracture prior to baseline and if they answered the biennial questionnaire at the start of each follow-up period. There were 103,799 participants in 1990, which serves as the baseline year for this analysis, with 14 years of follow-up for the wrist fracture analysis and 22 years of follow-up for the hip fracture analysis. Updated information on gout status and on all covariates was obtained during the follow-up period, and this updated information was used in the analysis. The study protocol was reviewed and approved by the Brigham and Women's Hospital Institutional Review Board.
Ascertainment of gout. Participants were asked whether they had received a physician's diagnosis of gout and the date of first occurrence of gout, with responses submitted on the questionnaires administered in 1982, 1984, 1986, and 1988 . In 2002, participants were asked whether they had ever received a physician's diagnosis of gout and the year of diagnosis. Participants were asked about a diagnosis of gout on subsequent biennial questionnaires. Starting in 2001, a supplementary questionnaire was mailed to participants with self-reported incident gout who received the gout diagnosis in 1980 onward, to confirm the report and year of diagnosis and ascertain whether the cases met the American College of Rheumatology gout classification criteria (40) .
Ascertainment of covariates. Potential confounders were included as covariates in our analysis (4, (41) (42) (43) . Age, BMI (calculated by dividing the weight [expressed in kilograms] by the square of the height [expressed in meters]), race, smoking status (never, past, or current), physical activity (expressed in metabolic equivalent task scores), falls during the past year (none, 1-2 falls, or $3 falls), history of hypertension, diabetes, or chronic renal failure, menopausal status and postmenopausal hormone replacement therapy use, and history of thiazide or furosemide use were ascertained from the biennial questionnaires. Self-reported weight was found to be highly reliable (r 5 0.97), as determined among a subset of participants who underwent direct measurement of their weight (44) . Physical activity reported on the questionnaires has been validated previously in a similar cohort, in comparison with physical activity diaries (r 5 0.79) (45). Selfreported hypertension (46) and diabetes (47) were previously validated in this cohort. Race was self-reported and categorized in this analysis as white or nonwhite.
Diet was assessed with the use of semiquantitative foodfrequency questionnaires (FFQs) that inquired about the average intake of .130 individual food items and .20 individual beverages during the previous year. The participants were asked to complete FFQs in 1990 FFQs in , 1994 FFQs in , 1998 FFQs in , 2002 FFQs in , 2006 FFQs in , and 2010 . Intake of specific dietary factors was computed from the reported frequency of consumption of each specified unit of food and from United States Department of Agriculture data on the content of the relevant nutrient in specified portions. The FFQ also inquired about intake of sugar-sweetened beverages (regular cola, other carbonated soda, and punch). The cohort was divided into quintiles of nutrient intake. Nutrient values were adjusted for total energy intake to determine the nutrient composition of the diet independent of the total amount of food eaten. The FFQ also inquired about the use of calcium supplements, vitamin D supplements, and multivitamins. The intakes of supplemental calcium, vitamin A, and vitamin D in multivitamins or in isolated form were determined according to the brand and the frequency of reported use. The FFQ has been extensively validated (48) .
Ascertainment of wrist or hip fracture. On the 1982 questionnaire, participants were asked to report all previous wrist and hip fractures (date, exact bone site, and circumstances leading to the fracture), and on all subsequent biennial questionnaires, they were asked to report incident wrist and hip fractures. Supplemental questionnaires were mailed to those nurses who reported an incident case of wrist or hip fracture, to obtain additional information, including the circumstances leading to the fracture. Only fractures of the proximal femur were included in the definition of a hip fracture, and forearm fractures included only those of the distal radius. We relied on self-reported hip and wrist fractures in this cohort. In a validation study, selfreported hip and wrist fractures were found to be highly reliable (46) . Similar to other analyses of wrist or hip fractures in the Nurses' Health Study (49) (50) (51) , only wrist and hip fractures that were attributable to low-level or moderate-level trauma (e.g., slipping, tripping, falling from the height of a chair) were considered to be cases for this analysis. Cases that arose from a highlevel traumatic event (e.g., motor vehicle accident, fall from a ladder, fall down a flight of stairs, horseback riding accident, skiing accident) were excluded from the analysis.
Statistical analysis. The study design was prospective; information on gout status and the covariates of interest was collected before the wrist or hip fracture diagnosis. For the analysis of the association between gout and wrist fracture, since the biennial questionnaires from 2006 onward did not ask about wrist fractures, the person-time of follow-up for each participant was counted from the date on which the questionnaire was returned until 1) the date at which the wrist fracture was diagnosed, 2) death, or 3) May 31, 2004, whichever occurred first. Participants were censored if they reported a hip fracture during the follow-up period.
For the analysis of the association between gout and hip fracture, the person-time of follow-up for each participant was counted from the date on which the biennial questionnaire was returned until 1) the date at which the hip fracture was diagnosed, 2) death, or 3) May 31, 2012, whichever occurred first. Participants were censored if they reported a wrist fracture during the follow-up period.
Information on gout status and other covariates was collected from the baseline questionnaire and updated on subsequent questionnaires. We allocated person-time of followup according to exposure status at the start of each follow-up period. Period-specific categories of gout status and other covariates were used in the analysis.
We used Cox proportional hazards models to simultaneously adjust for potential confounders. The variables considered in these models were age, BMI (as a continuous variable and in categories [,22 kg/m ), race (white or nonwhite), smoking status (never, past, or current), physical activity level (quintile groups), history of falls during the past year (none, 1-2 falls, or $3 falls), alcohol intake (none, 0.1-4.9 gm/day, 5-14.9 gm/day, or $15 gm/day), caffeine intake, quintiles of dietary intakes of calcium, vitamin D, vitamin A, vitamin C, animal and vegetable protein, and sugarsweetened beverages, self-reported hypertension, diabetes, or chronic renal failure, postmenopausal status, postmenopausal hormone replacement therapy use, and history of thiazide or furosemide use. We calculated 95% confidence intervals (95% CIs) for all relative risks (RRs). All P values are 2-tailed. All data were analyzed using SAS software, version 9.4 (SAS Institute).
RESULTS
Gout and wrist fracture risk. The characteristics of the women according to gout status in 1990 are shown in Table 1 . In 1990, 2,225 of the participants reported having received a diagnosis of gout. Women with gout were slightly older, had a higher BMI, had less physical activity, were more likely to be current smokers, were more likely to have hypertension, diabetes, or osteoporosis, and were more likely to be taking a thiazide diuretic.
During 1,296,844 person-years of follow-up over a 14-year follow-up period, there were a total of 3,769 cases of incident wrist fracture. Over the 14-year follow-up, there were 8,834 women who reported having a diagnosis of gout. Among the women with gout, there were 107 incident cases of wrist fracture. For our analyses, the updated responses with regard to gout status and all covariate information were included for each time period. In analyses adjusted for age, a history of gout was not significantly associated with a risk of wrist fracture (RR 1.07, 95% CI 0.88-1.30) ( Table 2 ). The results were not substantially changed in the analyses after multivariable adjustment (RR 1.12, 95% CI 0.92-1.36).
We also performed stratified analyses. The association between gout and wrist fracture was similar between women ages $65 years and those ages ,65 years, and between women with a BMI of $25 kg/m 2 and those with a BMI of ,25 kg/m 2 . Moreover, the association between gout and wrist fracture was similar in women regardless of whether or not they had a history of thiazide use or diabetes.
Gout and hip fracture risk. During 1,878,333 person-years of follow-up over a 22-year follow-up period, there were 2,147 cases of incident hip fracture. Over the 22-year follow-up, there were 14,382 women who reported having received a diagnosis of gout. Among the women with gout, there were 117 incident cases of hip fracture. For our analyses, the updated responses with regard to gout status and all covariate information were included for each time period. After adjustment for age, a history of gout was associated with a higher risk of hip fracture (RR 1.40, 95% CI 1.16-1.69) ( Table 2) . After multivariable adjustment, a history of gout remained significantly associated with a risk of incident hip fracture (RR 1.38, 95% CI 1.14-1.68).
The association between gout and hip fracture was similar in women with a BMI of $25 kg/m 2 and those with a BMI of ,25 kg/m 2 , and also was similar in women with and those without a history of diabetes. The association between gout and hip fracture was stronger in women who were younger than age 65 years (RR 2.19, 95% CI 1.35-3.56) compared with those ages 65 years or older (RR 1.28, 95% CI 1.04-1.58) (P for interaction 5 0.02). The association between gout and hip fracture was stronger in women taking thiazides (RR 1.92, 95% CI 1.37-2.70) than in those not taking thiazides (RR 1.16, 95% CI 0.92-1.48) (P for interaction 5 0.02).
DISCUSSION
This is the first prospective study in which an increased risk of hip fracture was demonstrated in women with gout. To date, there have been no prior prospective studies on gout and risk of incident wrist or hip fracture in women. In this large prospective cohort study of women, we found a modestly increased risk of hip fracture among women with gout, but no statistically significant association between gout and incident wrist fracture.
This study has several strengths, including the prospective study design. Additional strengths include the large number of incident hip and wrist fracture events, the large number of gout cases, the long follow-up period, and detailed, repeated assessments of covariates. Prior studies have yielded conflicting findings on the association between the serum uric acid level and BMD. Most of those prior studies, in which either a positive association (27) (28) (29) or an inverse association (30) between serum uric acid levels and BMD was demonstrated, were cross-sectional analyses. The more recent National Health and Nutrition Examination Survey (NHANES) study showed no association between serum uric acid levels and BMD (31), a finding that was corroborated with data from animal models, although the NHANES study was also cross-sectional. Most recently, the prospective Rotterdam Study demonstrated a positive association between higher serum uric acid levels and BMD (35) .
Results from studies that have examined the association between serum uric acid levels and fracture have also been conflicting. A cross-sectional study in Australian men showed an inverse association between serum uric acid levels and the prevalence of fractures (32) , and the prospective MrOS study showed an association of higher serum uric acid levels with a decreased risk of nonspine fracture, but no association with hip fracture (33) . These 2 studies were conducted in men only. While the more recent Cardiovascular Health Study prospectively investigated the association between serum uric acid levels and hip fracture in both men and women, a significant positive association between serum uric acid levels and hip fracture was demonstrated in men only (34) . In the prospective Rotterdam Study, a slightly lower risk of any type of incident fracture was observed, but no association with specifically hip fracture was seen, and the findings did not differ between men or women (35) .
However, all of these studies examined the association between serum uric acid levels and BMD or between serum uric acid levels and fracture, but no study to date has prospectively examined the association between a history of gout and fracture risk. This distinction may be important, because gout reflects a state in which uric acid exists at supersaturated concentrations (21) , and therefore it may be acting as a prooxidant that is contributing to high oxidative stress (22) . In addition to hyperuricemia, gout is characterized by the formation of uric acid crystals and inflammation, features that distinguish it from pure hyperuricemia, which is not associated with clinical symptoms.
Importantly, uric acid crystals have been shown to activate the NLRP3 inflammasome (a NOD-like receptor protein formerly named NALP3, also called cryopyrin) (36) , which is an important driver of proinflammatory cytokines (37) . This environment of active inflammation can disrupt osteoblast function (52) and promote osteoclastogenesis (23, 24) , thereby potentially increasing the risk of fracture at more vulnerable sites such as the hip (53, 54) . Our finding of a positive association between gout and hip fracture, but no association with wrist fracture, supports the importance of studying risk factors for different fracture sites separately, since the risk factors can vary by site (53, 55, 56) . Whereas the hip fracture risk increases with age and is associated with markers of poorer health and frailty, including comorbid conditions, impaired neuromuscular function, and lower physical activity (59) (60) (61) (62) , the wrist fracture risk does not increase with age and often occurs as a result of a fall in women with low BMD who are otherwise relatively healthy and physically active and have intact neuromuscular function (55, 61) .
We also found effect modification of the association between gout and hip fracture by age and thiazide diuretic use. The association between gout and hip fracture was stronger in women younger than age 65 years compared with those ages 65 years or older. The Rotterdam Study recently demonstrated a significant effect modification by age for the association between serum uric acid levels and any type of fracture (35) . Although thiazide use has been demonstrated to be protective against risk of hip fracture (62) (63) (64) , its use is associated with increased gout risk (43, 65, 66) . Since there have been no prior studies on the association between gout and incident wrist or hip fracture risk, further studies are needed to fully elucidate the interaction between age, thiazide use, gout, and hip fracture risk.
There are several limitations to our observational study. There is the possibility of residual or unmeasured confounding. For example, we did not have information on BMD measurements in our participants. We relied on selfreports for the history of gout. We were unable to study the effect of urate-lowering therapy on fracture risk and whether such therapy may have modified some of the fracture risk in participants with gout. We did not have enough cases to examine the relationship between gout and vertebral fracture, which may have different risk factors, pathophysiology, and biomechanics. Finally, since our study population was female and almost entirely white, our findings are not necessarily generalizable to men or to other races.
In this large prospective cohort study, a history of gout was associated with a modestly increased risk of hip fracture in women, but not associated with a risk of wrist fracture in women. If the association between gout and fracture risk is confirmed in future studies, it will be important to examine whether treatment of gout could impact the fracture risk.
